Frontiers in Oncology

Clonal hematopoiesis of indeterminate potential and cancer immunotherapy: a host-intrinsic immune-inflammatory modifier of treatment efficacy and toxicity

By Longjun Huang, Jiahao Sheng, Luyang Chi, Yehan Xu, Yun Wang

Figure 1 from Frontiers in Oncology — Figure 1. Huang et al.

ReviewMechanisms

The paper

Longjun Huang, Jiahao Sheng, Luyang Chi, Yehan Xu, Yun Wang

Beijing University of Chinese Medicine; Zhejiang Chinese Medical University

Frontiers in Oncology, 23 Sep 2026

doi.org/10.3389/fonc.2026.1966718 PubMed 42846836

medRxiv2 Oct 2026
ASXL1-mutant clonal hematopoiesis links to aortic valve disease
International Journal of Molecular Sciences4 Oct 2026
Donor TET2 variant linked to lower stem cell transplant survival
medRxiv2 Oct 2026
Clonal hematopoiesis is linked to frailty in human cohorts
HemaSphere7 Oct 2026
Blood-cell mutation patterns linked to cancer progression